Dr. Christoforidis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3712 North Swan Road
Tucson, AZ 85712Phone+1 520-881-1400Fax+1 520-881-1418
Education & Training
- Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolFellowship, Surgical Retina and Vitreous, 2003 - 2005
- Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolFellowship, Surgical Retina and Vitreous, 2001 - 2003
- University of Maryland Medical Center Midtown CampusResidency, Ophthalmology, 1996 - 1999
- National Institutes of Health Clinical CenterFellowship, Research, 1993 - 1996
- Mount Carmel Health SystemInternship, Internal Medicine, 1992 - 1993
- Ohio State University College of MedicineClass of 1991
Certifications & Licensure
- AZ State Medical License 2012 - 2027
- OH State Medical License 1999 - 2013
- MA State Medical License 2001 - 2007
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Publications & Presentations
PubMed
- 73 citationsEpiretinal membrane: optical coherence tomography-based diagnosis and classificationWilliam Stevenson, Claudia M Prospero Ponce, Daniel R. Agarwal, Rachel Gelman, John B. Christoforidis
Clinical Ophthalmology. 2016-03-29 - 29 citationsPlasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema.Lee M. Jampol, Adam R. Glassman, Danni Liu, Lloyd Paul Aiello, Neil M. Bressler
Ophthalmology. 2018-03-07 - 82 citationsInflammatory mechanisms of idiopathic epiretinal membrane formation.Malav Joshi, Shivi Agrawal, John B. Christoforidis
Mediators of Inflammation. 2013-11-11
Press Mentions
- Effect of Initial Management with Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients with Diabetic Macular Edema Involving the Center of the Macula and Good Visual AcuityMay 1st, 2019
Professional Memberships
- Member
- Association for Research & Vision in Ophthalmology (ARVO)Member
- Retina SocietyMember
- American Society of Retina SpecialistsMember
Other Languages
- French, Greek, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: